Examining International Examples of Early Access Pathways to Innovative Oncology Drugs

February 12, 2024 11:45am

Tara Cowling
President & Managing Principal
Medlior

  • Overview of market access process in UK, Italy, Germany, France, Australia, and Canada
    • Early access pathways in those countries from pre-HTA to post-HTA
  • Examining how RWE is leveraged in those pathways and countries
    • How public funding is utilized during conditional approval period
  • Exploring opportunities for Canadian data to facilitate coverage with evidence decisions